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Abstract
Background: Myelin oligodendrocyte glycoprotein (MOG)-reactive T-helper (Th)1 cells induce conventional
experimental autoimmune encephalomyelitis (cEAE), characterized by ascending paralysis and monocyte-
predominant spinal cord infiltrates, in C57BL/6 wildtype (WT) hosts. The same T cells induce an atypical form of EAE
(aEAE), characterized by ataxia and neutrophil-predominant brainstem infiltrates, in syngeneic IFNγ receptor (IFNγR)-
deficient hosts. Production of ELR+ CXC chemokines within the CNS is required for the development of aEAE, but
not cEAE. The cellular source(s) and localization of ELR+ CXC chemokines in the CNS and the IFNγ-dependent
pathways that regulate their production remain to be elucidated.
Methods: The spatial distribution of inflammatory lesions and CNS expression of the ELR+ CXC chemokines, CXCL1
and CXCL2, were determined via immunohistochemistry and/or in situ hybridization. Levels of CXCL1 and CXCL2,
and their cognate receptor CXCR2, were measured in/on leukocyte subsets by flow cytometric and quantitative PCR
(qPCR) analysis. Bone marrow neutrophils and macrophages were cultured with inflammatory stimuli in vitro prior
to measurement of CXCL2 and CXCR2 by qPCR or flow cytometry.
Results: CNS-infiltrating neutrophils and monocytes, and resident microglia, are a prominent source of CXCL2 in
the brainstem of IFNγRKO adoptive transfer recipients during aEAE. In WT transfer recipients, IFNγ directly
suppresses CXCL2 transcription in microglia and myeloid cells, and CXCR2 transcription in CNS-infiltrating
neutrophils. Consequently, infiltration of the brainstem parenchyma from the adjacent meninges is blocked during
cEAE. CXCL2 directly stimulates its own expression in cultured neutrophils, which is enhanced by IL-1 and
suppressed by IFNγ.
Conclusions: We provide evidence for an IFNγ-regulated CXCR2/CXCL2 autocrine/paracrine feedback loop in
innate immune cells that determines the location of CNS infiltrates during Th1-mediated EAE. When IFNγ signaling
is impaired, myeloid cell production of CXCL2 increases, which promotes brainstem inflammation and results in
clinical ataxia. IFNγ, produced within the CNS of WT recipients, suppresses myeloid cell CXCR2 and CXCL2
production, thereby skewing the location of neuroinflammatory infiltrates to the spinal cord and the clinical
phenotype to an ascending paralysis. These data reveal a novel mechanism by which IFNγ and CXCL2 interact to
direct regional recruitment of leukocytes in the CNS, resulting in distinct clinical presentations.
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Background
In multiple sclerosis (MS), a multifocal inflammatory de-
myelinating disease of the central nervous system (CNS),
the distribution of lesions can vary widely between pa-
tients, resulting in distinct clinical phenotypes. In some
patients, lesion burden is dispersed fairly evenly across
CNS compartments, while in others it is skewed either to-
wards the spinal cord or supratentorial white matter [1, 2].
The histopathology of MS lesions, including the presence
of specific immune subsets and factors, is also diverse.
Similarly, lesion distribution and composition is heteroge-
neous in experimental autoimmune encephalomyelitis
(EAE), which is widely used as an animal model of MS.
Although little is known about the factors that deter-
mine the composition or location of lesions in MS, sev-
eral studies have demonstrated a pivotal role of IFNγ in
EAE. Adoptive transfer of Th1-polarized, myelin oligo-
dendrocyte glycoprotein (MOG)-reactive T cells derived
from C57BL/6 wildtype (WT) mice into syngeneic wild-
type (WT) hosts results in a high incidence of “conven-
tional” EAE (cEAE), which manifests as an ascending
paralysis secondary to monocyte-rich inflammatory infil-
tration of the thoracolumbar spinal cord. Conversely,
transfer of the same population of Th1 cells into IFNγ re-
ceptor knockout (IFNγRKO) hosts, or transfer of IFNγKO
CD4+ T cells into WT hosts, results in a high incidence of
atypical EAE (aEAE), characterized by gait imbalance and
brainstem or cerebellar inflammation [3–5]. IFNγ induces
expression of chemokines, such as CCL2 and CXCL10 [6],
and endothelial adhesion molecules, such as VCAM-1 and
P-selectin [7, 8], in the CNS. Collective induction of these
molecules promotes neuroinflammation by facilitating the
passage of T cells and monocytes into the CNS parenchy-
mal white matter. In fact, cEAE is dependent on spinal
cord expression of CCR2 and α4β1 integrin, the receptors
for CCL2 and VCAM-1, respectively [5, 9, 10]. In contrast,
aEAE lesion development correlates with production of
ELR+ CXC chemokines in the brainstem and is neutrophil
dependent [5]. The destructive effects of neutrophil infil-
tration in CNS white matter have been demonstrated in
several different animal models [11, 12]. Hence, the rela-
tive importance of particular cytokine and chemokine
pathways varies across different models of EAE, which can
translate into differential responsiveness to individual
disease-modifying therapies [3–5, 13, 14].
For the future development of personalized ap-
proaches to MS therapy, it will be important to acquire
a detailed understanding of the spectrum of molecular
and cellular pathways that underlie similar, as well as di-
vergent, clinical courses of autoimmune demyelinating
disorders. In the current study, we investigate the cellu-
lar source and spatial localization of the ELR+ CXC che-
mokines, CXCL1 and CXCL2, in C57BL/6 IFNγRKO
mice with aEAE, the factors that trigger CXCL2
production, and the mechanism by which IFNγ regulates
neutrophil infiltration of the brainstem.
Methods
Mice
Eight- to 14-week-old CD45.1 congenic and WT C57BL/
6 mice were obtained from Charles River/NCI Fredrick.
IFNγRKO and RosamT/mG mice were originally obtained
from Jackson Laboratory and bred in the University of
Michigan vivarium. LysM-Cre:IFNγRflox/flox mice were
obtained from Athena Soulika, University of
California-Davis [15]. All mice were housed in microiso-
lator cages under specific pathogen-free conditions. All
animal protocols were approved by the University of
Michigan Committee on Use and Care of Animals.
Antibodies and reagents
For flow cytometry, the following antibodies were ob-
tained from eBioscience: PECy7-α-CD11b (M1/70),
eFluor450-α-CD45 (30-F11), and PerCpCy5.5-α-Ly6C
(HK1.4). Allophycocyanin cy7-α-Ly6G (IA8) was from
BD Biosciences. For immunofluorescent histology, pri-
mary antibodies included rabbit α-glial fibrillary acidic
protein (GFAP) (Gibco), rat α-mouse CD45 (IBL-5/15,
Millipore), goat α-mouse CXCL2 (R&D Systems), goat
α-mouse CXCL1 (R&D Systems), rat α-mouse Ly6G
(IA8, BD Biosciences), and hamster α-mouse CD3ε (BD
Biosciences). All secondary antibodies were from Life
Technologies, including AlexaFluor594 donkey-α-goat
IgG, AlexaFluor488 goat-α-rat IgG, goat α-hamster, and
AlexaFluor647 goat-α-rabbit IgG. For in vitro cultures,
G-CSF was obtained from Amgen; recombinant mouse
(rm) IFNγ, rmIL-12, rmCXCL2, rmIL-1β, and rmCXCL1
were from R&D Systems.
Induction and scoring of EAE
Donor mice were immunized subcutaneously with 100 μg
MOG35–55 (MEVGWYRSP-FSRVVHLYRNGK, Biosyn-
thesis) in CFA (Difco) across four sites over the flanks. In-
guinal, axial, and brachial lymph nodes were harvested
14 days post-immunization, pooled, homogenized, and
passed through a 70-μm strainer (BD Falcon). Cells were
cultured with MOG35–55 (50 μg/mL) in the presence of
rmIL-12 (6 ng/mL) and rmIFNγ (2 ng/mL). At 96 h, CD4
T cells were isolated by column separation with CD4
(L3T4) magnetic microbeads, according to the manu-
facturer’s instructions (Miltenyi). CD4 T cells (> 80%
pure) were transferred i.p. into naïve hosts (5 × 106
cells/ mouse). Adoptive transfer recipients were moni-
tored on a daily basis by an examiner who was blinded
to the experimental groups. Mice were scored for sever-
ity of conventional and atypical signs of EAE using
established scales [4, 5].
Stoolman et al. Journal of Neuroinflammation  (2018) 15:208 Page 2 of 11
Construction of bone marrow chimeric mice
Femurs and tibiae of IFNγRKO or ROSAmT/mG mice
were flushed with PBS using a 26-gauge needle to ob-
tain donor bone marrow cells. Cells were ACK lysed
and suspended in cold PBS for intravenous injection
into CD45.1 congenic hosts, which had been sub-
jected to 13 Gy of irradiation (orthovoltage X-ray
source) split into two doses, 3 h apart. Hosts were
given 2.5 × 106 bone marrow cells from each donor
source (1:1 ratio) and allowed to reconstitute for at
least 6 weeks before further use. Chimerism was veri-
fied by flow cytometric analysis of peripheral blood
mononuclear cells.
Histochemical procedures
Mice were perfused with 1× PBS and 4% paraformalde-
hyde (PFA). CNS tissues were harvested, post-fixed in 4%
PFA for 96 h, decalcified in 0.5 M EDTA for 96 h, and
transferred into 30% sucrose for at least 48 h prior to em-
bedding in OCT and storage at − 80 °C. Spinal cord and
brain tissues were cryosectioned at 10 μm. Sections were
incubated in 1× PBS in a humidified chamber, followed by
blocking solution (1× PBS 7.4 pH, 10% Normal Donkey
Serum, 0.5% Triton-X100) for 1 h. Primary antibodies
were applied overnight at 4 °C. For secondary antibody
staining, sections were incubated with AlexaFluor594
donkey-α-Goat IgG, rinsed in PBS, and then incubated
with AlexaFluor488 goat-α-rat IgG and AlexaFluor647
goat-α-rabbit IgG followed by DAPI (100 ng/mL).
Sections were washed and mounted on slides (Antifade
Reagent, Southern Biotech). Confocal images were
acquired using a Nikon A-1 confocal microscope (Nikon
PlanApoVC × 20, × 40, or × 60/1.40 oil) with diode-based
laser system and NIS Elements software.
For in situ hybridization, cryosections of CNS tissue
were incubated with Proteinase K (10 μg/mL, Sigma) for
20 min followed by incubation with digoxigenin-labeled
cRNA probes (DIG-11-UTP; Roche). Sense and
anti-sense CXCL2 probes were transcribed from a
1.08-kb mouse CXCL2 cDNA, a gift of Dr. Luc Vallières,
Laval University [16]. Hybridization was performed at
55 °C in 50% formamide with a final concentration of
100–200 ng of DIG probe/mL [17]. Following stringency
washes, hybridization signal was identified with
α-Digoxigenin-AP (Roche). Colorimetric images were
converted to red as positive signal and black as negative,
and overlaid onto DAPI stain of in situ sections. Images
were taken with a Nikon Eclipse Ti-U with a Nikon
D5-U2 camera using NIS Elements software. Appropri-
ate processing including image overlays and black level
and brightness adjustments were performed in Adobe
Photoshop CC2014 and applied equally to all samples
and controls.
CNS mononuclear cell isolation
CNS tissue was harvested and dissected into the spinal
cord and brainstem. Each specimen was homogenized in
1 mL PBS containing a protease inhibitor cocktail
(Roche) and centrifuged at 800×g for 10 min. Superna-
tants were stored at − 80 °C for subsequent chemokine
analysis. Infiltrating cells were isolated over a 27% Per-
coll gradient. Cells were quantified with a Cellometer
AutoT4 automated cell counter, excluding dead or dying
cells with trypan blue (Nexcelom).
Flow cytometry
For surface staining, cells were resuspended in PBS + 2%
fetal bovine serum (FBS) containing Fc Block (50 ng/mL)
and Fixable Viability Dye efluor 506 (eBioscience) prior to
incubation with fluorochrome-conjugated antibodies. For
intracellular staining, cells were incubated with Brefeldin
A (10 μg/mL) for 4 h in the presence or absence of
stimulation conditions. Cells were labeled with
fluorochrome-conjugated cell surface antibodies as de-
scribed above, fixed in 4% PFA, permeabilized with 0.5%
saponin, and incubated with fluorochrome-conjugated
α-cytokine or chemokine antibodies. Stained cells were
run on a FACS Canto II flow cytometer (v6.1.3, Becton
Dickenson) or sorted on the FACS Aria II using FACS
Diva software. Data was analyzed using FlowJo software
(v10.0.7r2, Treestar).
In vitro monocyte and neutrophil assays
Eight- to 14-week-old mice were euthanized; the femur
and tibia were flushed and passed through a cell strainer
(70 μm) with repeated washes. For monocyte stimula-
tion, whole bone marrow was plated in complete media
(RPMI with 10% FBS, L-Glutamine (2 mM, Gibco), Pen/
Strep (1:100, Gibco), sodium pyruvate (12.5 μM, Gibco),
and 2-mercaptoethanol (55 μm, Gibco)) in the presence
of Brefeldin A (10 μg/mL) with lipopolysaccharide (LPS)
(1 μg/mL), with or without IFNγ (2 ng/mL). Four hours
later, the cells were stained for intracellular CXCL2 and
subjected to flow cytometric analysis. Neutrophils were
purified from bone marrow cell suspensions using an
α-Ly6G microbead kit (Miltenyi). Purified neutrophils
were plated in complete media in the presence or absence
of CXCL2 (20 ng/mL), CXCL1 (20 ng/mL), granulocyte
colony-stimulating factor (G-CSF) (25 ng/mL), IFNγ
(2 ng/mL), or IL-1β (10 ng/mL) and isolated following 1 h
in culture to examine CXCL2 mRNA expression.
RNA isolation
Cells from FACS or in vitro cell culture were spun down
and resuspended in 1 mL Trizol (Life Technologies). For
RNA extraction, 200 μL of chloroform was added to
samples and mixed prior to centrifugation at 18000×g.
Chloroform layer was moved to a fresh tube with 500 μL
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cold isopropanol, mixed and incubated for 15 min prior
to purifying the RNA out using the RNeasy MiniKit
(Qiagen) with column DNase digestion per manufac-
turer’s instructions.
RT- and q-PCR
RT-PCR was performed using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems) per
manufacturer’s instructions. For q-PCR, TaqMan Univer-
sal Master Mix and primer/probe sets for CXCL2,
CXCR2, and GAPDH were purchased from Applied Bio-
systems and run on a MyIQ system using iQ5 software
(BioRad) as described in manufacturer’s instructions.
Statistical analysis
Statistical analyses were performed using GraphPad
Prism software. Unless otherwise stated, all graphs are
expressed as means ± SEM. Comparisons of cell num-
bers, or of transcript levels in myeloid cells isolated from
WT versus IFNγRKO hosts, were done using an un-
paired Student’s t test. Comparisons of transcript levels
in paired neutrophils or monocytes/macrophages isolated
from mixed BM chimeras, or in myeloid cells cultured in
vitro under different conditions, were done using a
paired Student’s t test. A p value < 0.05 (*) was consid-
ered significant. p < 0.01 (**) and p < 0.001 (***).
Results
Inflammatory cells accumulate in the peri-pontine meninges
during the early stages of both cEAE and aEAE, but only
infiltrate the brainstem parenchyma of mice with aEAE
Our laboratory previously reported that neutrophils are
more plentiful in the brainstems of IFNγRKO adoptive
transfer recipients at the peak of aEAE compared with
WT recipients at the peak of cEAE [5]. In contrast, at
disease onset we found comparable numbers of
brainstem-infiltrating CD11b+Ly6G+ neutrophils, as well
as CD11b+Ly6G− monocytes/macrophages, in IFNγRKO
and WT recipients (Additional file 1: Figure S1). Immu-
nohistochemical studies demonstrated that infiltrating
inflammatory cells penetrate deep into the brainstem
parenchyma at aEAE onset but are confined to the
peri-pontine meninges at cEAE onset (Additional file 2:
Figure S2). We detected T cells and neutrophils adjacent
to the lateral recess of the fourth ventricle in every spe-
cimen examined, suggesting that leukocytes generally
enter the brainstem via the choroid plexus, as previously
reported in active immunization models [18]. We con-
cluded that IFNγR signaling does not impede the early
passage of inflammatory cells into the choroid plexus of
adoptive transfer recipients, or their migration from the
choroid plexus into the fourth ventricle and meninges,
but suppresses their further extension into, and subse-
quent persistence in, the adjacent white matter paren-
chyma. As opposed to the anti-inflammatory role of IFNγ
signaling in the brainstem, it is required for spinal cord in-
filtration since we find few inflammatory cells in the cords
of IFNγRKO, as opposed to WT, adoptive transfer recipi-
ents at any time point following adoptive transfer [5].
IFNγ suppresses CXCL2 expression by myeloid cells in the
brainstem during cEAE
The cellular subset that IFNγ modulates during cEAE to
suppress parenchymal brainstem inflammation has not
been definitively identified. MOG-specific Th1 cells in-
duce clinical signs of aEAE at a twofold higher incidence
in C57BL/6 conditional knockout mice that are IFNγR
deficient in Lysozyme M (LysM)-expressing cells, when
compared with their IFNγR-sufficient counterparts
(Table 1). There was no difference between the groups
in the incidence of clinical features characteristic of
cEAE. This finding implicates myeloid cells as an im-
portant target of IFNγ in WT hosts. The ELR+ CXC che-
mokine, CXCL2, is elevated in the brainstem during
aEAE and plays a critical role in the development of
ataxia [5, 19]. We questioned whether CNS myeloid cells
are the primary cellular source of CXCL2 in IFNγRKO
transfer recipients. Indeed, CXCL2 mRNA was
expressed at high levels in infiltrating monocytes/macro-
phages and neutrophils, as well as in microglia, FACS
sorted from brainstems at the initiation of aEAE (Fig. 1a).
CXCL2 mRNA was barely detectable above background
levels in CNS-infiltrating CD45+CD11b− cells, a cell sur-
face phenotype consistent with lymphocytes. Intracellu-
lar staining and flow cytometric analysis demonstrated
that neutrophils are the predominant producers of
CXCL2 protein among CNS inflammatory cells in mice
with aEAE (in terms of frequency of cells within the
CXCL2+ population), followed by microglia and macro-
phages/monocytes (Fig. 1b). We did not detect CXCL2
protein in CNS CD45+CD11b− lymphoid cells or in
CD45− non-hematopoietic cells. CXCL1, another member
of the ELR+ CXC chemokine family, was not detectable in
any of the inflammatory cell subsets (data not shown).
Table 1 IFNgR deficiency in Lysozyme M (LysM)-expressing myeloid cells increases susceptibility to EAE
Genotype Incidence of aEAE Average cumulative clinical score aEAE Incidence of cEAE Average cumulative clinical score cEAE
Cre− 4/13 (30.8%) 10.5 ± 1.11 9/13 (69.2%) 26.7 ± 1.93
Cre+ 16/26 (61.5%) 6.44 ± 0.226 18/26 (69.2%) 32.4 ± 1.04
LysM-Cre:IFNgRflox/flox mice and their non-Cre expressing littermates were injected with MOG35–55-reactive encephalitogenic Th1 cells. Mice were evaluated for
signs of aEAE or cEAE on a daily basis by examiners blinded to group identity
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Consistent with the above findings, CXCL2 was
expressed within intraparenchymal inflammatory infil-
trates in brainstem sections obtained at peak aEAE, but
not in adjacent uninflamed white matter or in the
meninges (Fig. 2a). In immunohistochemical studies,
the CXCL2 producers were exclusively CD45+
hematopoietic cells (Fig. 2b; Additional file 3: Figure
S3). Many CD45+ cells that stained positively for
CXCL2 had multilobulated nuclei, indicative of neutro-
phils. GFAP-positive astrocytes, present at the border
of the inflammatory infiltrates, were CXCL2 negative.
We did not detect CXCL2 expression in the brainstem
of WT hosts with cEAE, either by in situ hybridization
or immunohistochemistry (unpublished data).
IFNγ suppresses CXCL2 in brainstem myeloid cells via a
cell intrinsic pathway
To investigate whether IFNγ directly suppresses
CXCL2 production in CNS myeloid cells during
EAE, we constructed mixed bone marrow chimeric
mice by reconstituting lethally irradiated CD45.1
congenic C57BL/6 hosts with a mixture of bone
marrow cells from IFNγR-sufficient and IFNγRKO
donors. IFNγR-sufficient donor cells were distin-
guished by expression of a tdTomato reporter gene.
Eight weeks later, the reconstituted chimeras were
injected with MOG-reactive Th1 cells in order to in-
duce EAE. The brainstem, spinal cord, and bone
marrow cells were harvested at EAE onset, and mye-
loid cell subsets from each donor pool were sub-
jected to qPCR. CXCL2 transcript levels were
consistently reduced in IFNγR-sufficient myeloid
cells compared with paired IFNγRKO myeloid cells
isolated from the CNS of individual chimeric mice
(Fig. 3a). In contrast, CXCL2 mRNA expression was
comparable in IFNγR-sufficient versus IFNγRKO
bone marrow neutrophils, and slightly lower in
IFNγRKO bone marrow monocytes.
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Fig. 1 CD45+CD11b+ myeloid cells are a primary source of CXCL2 in the brainstem during aEAE. a Neutrophils (CD45+CD11b+Ly6G+), monocytes/
macrophages (CD45hiCD11b+Ly6G−), microglia (CD45loCD11b+Ly6G−), and non-myeloid immune cells (CD45+CD11b−) were FACS sorted from the
brainstems of IFNγRKO mice at the onset of aEAE. CXCL2 mRNA was quantified by qPCR and normalized to GAPDH (n = 15 mice pooled from
two experiments). b Brainstem-infiltrating cells isolated at the onset of aEAE were stained on the cell surface with antibodies specific for myeloid
cell markers and intracellularly with αCXCL2 prior to flow cytometric analysis (n = 6 mice from two experiments)
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IFNγ suppresses expression of CXCR2 by brainstem-
infiltrating neutrophils
In a model of Listeria monocytogenes infection, IFNγ
downregulates expression of CXCR2 (the only receptor
for CXCL2 in mice) on neutrophils, thereby curtailing
their recruitment to the site of inflammation [20]. We
questioned whether IFNγ similarly suppresses CXCR2
expression on neutrophils during early stages of cEAE.
CXCR2 is rapidly internalized following ligation by its
cognate chemokine, such that cell surface CXCR2 levels
are not always a reliable indicator of CXCR2 expression.
Therefore, we chose to measure CXCR2 transcripts in
neutrophils harvested from mice with aEAE or cEAE by
qPCR. CXCR2 transcript levels were significantly higher
in neutrophils isolated from the brainstems and spinal
cords of IFNγRKO hosts at aEAE onset compared with
analogous neutrophils isolated from WT hosts at cEAE
onset (Fig. 3b). There was no difference in CXCR2 ex-
pression in neutrophils isolated from the bone marrow
of IFNγRKO versus WT hosts at the same time point, or
from naïve IFNγRKO versus WT mice. CXCR2 mRNA
was not expressed at detectable levels by microglia, or
CNS-infiltrating monocytes or lymphocytes, that were
FACS sorted from mice during either aEAE or cEAE
(data not shown).
We next compared CXCR2 mRNA expression in
IFNγ-responsive versus unresponsive neutrophils isolated
from the brainstems or spinal cords of mixed bone mar-
row chimeric mice with EAE, using the approach de-
scribed in Fig. 3a. CXCR2 mRNA levels were reproducibly
higher in IFNγRKO CNS-infiltrating neutrophils com-
pared to paired IFNγR-sufficient CNS-infiltrating neutro-
phils isolated from individual mice (Fig. 3c). In contrast,
there was no difference in CXCR2 mRNA expression
when comparing IFNγR-sufficient versus IFNγRKO bone
marrow neutrophils from the same mice. This indicates
that during EAE, IFNγ directly inhibits CXCR2, as well as
CXCL2, production by IFNγ-responsive neutrophils, spe-
cifically within the CNS microenvironment.
IFNγ regulates a CXCL2 autocrine feedback loop in
neutrophils
IL-17 is a potent inducer of ELR+ CXC chemokines and
plays a critical role in initiating neutrophil migration to the
brainstem white matter in some models of aEAE [13, 19].
However, the model of aEAE employed in the present
study is IL-17 independent [5]. This raises the question of
which factors actively drive CXCL2 production in the
brainstem of C57BL/6 IFNγRKO mice following the adop-
tive transfer of MOG35–55-reactive CD4+ Th1 cells. To ad-
dress that issue, we screened soluble factors, known to be
upregulated in the brainstems over the spinal cords of
mice with aEAE [5], for their ability to stimulate CXCL2
production in naïve C57BL/6 bone marrow neutrophils in
vitro. CXCL2 mRNA was upregulated in purified neutro-
phils following culture either with recombinant G-CSF,
CXCL1, or CXCL2 itself (Fig. 4a). In contrast, neither re-
combinant CCL3 nor CCL4 altered the expression of
CXCL2 transcripts in cultured neutrophils (data not
shown). Furthermore, neutrophil CXCR2 expression was
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Fig. 2 CXCL2 is produced by CD45+ cells in the brainstem infiltrates during aEAE. a Brainstem tissue was harvested from an IFNγRKO host at aEAE
onset (clinical score 1). Sections were subjected to in situ hybridization to detect CXCL2 mRNA (red) combined with a DAPI (blue) counter stain.
b Brainstem sections from a mouse with aEAE (clinical score 3) were stained with monoclonal antibodies specific for CD45 (green), GFAP (white),
and CXCL2 (red) and counterstained with DAPI (blue). Arrows indicate CXCL2+ CD45+ cells. Arrow heads indicate GFAP+ astrocytes
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not affected by culture with any of the recombinant che-
mokines. Induction of CXCL2 mRNA in neutrophils cul-
tured with recombinant CXCL2 was enhanced by IL-1β
(Fig. 4b). IFNγ suppressed CXCL2 mRNA upregulation in
neutrophils cultured with CXCL2, either alone or com-
bined with IL-1β, but had no effect on CXCL2 mRNA
levels in G-CSF-stimulated neutrophils (Fig. 4a, b).
Ligation of toll-like receptors (TLRs) on monocytes, mac-
rophages, and microglia is known to upregulate CXCL2
expression [21, 22]. To examine whether CXCL2 expres-
sion in non-granulocytic myeloid cells could be regulated
by IFNγ, we cultured bone marrow-derived monocytes
with LPS in the presence or absence of IFNγ. LPS trig-
gered robust CXCL2 expression in bone marrow mono-
cytes, which was inhibited by IFNγ (Fig. 4c).
CXCL1 is expressed by non-hematopoietic CNS resident
cells during EAE
CXCL1 and CXCL2 are both ligands for CXCR2. In a
previous study, we made the paradoxical observation
that although CXCL2 is disproportionately upregulated
in the brainstem of IFNγRKO mice with aEAE in com-
parison to WT mice with cEAE, CXCL1 expression is
actually expressed at elevated levels in the brainstem
and spinal cord of the WT adoptive transfer recipients
[5]. Our discovery that IFNγ downregulates CXCR2 on
neutrophils (Figs. 3 and 4) provides one explanation for
why CXCL1 is unable to compensate for low CNS
CXCL2 levels in WT adoptive transfer recipients and
promote parenchymal brainstem infiltration. A comple-
mentary hypothetical explanation is that CXCL1 is pro-
duced by a different cell type in the brainstem than
CXCL2, at a location that does not facilitate migration
into the white matter. Indeed, immunohistochemical
analyses showed that the choroid plexus is a major
source of CXCL1 during EAE in WT, as well as
IFNγRKO, mice (Fig. 5a and data not shown). This
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Fig. 3 IFNγ signaling directly regulates CXCR2 expression by
neutrophils. a IFNγR-sufficient and IFNγRKO neutrophils (left panels)
and monocytes/macrophages (right panels) were FACS sorted from
the brainstems (upper panels), spinal cords (middle panels), and bone
marrow (lower panels) of mixed bone marrow chimeric mice. CXCL2
transcript levels were measured by qPCR and normalized to GAPDH
(n = 13 chimeric mice from two experiments). b CD45+CD11b+Ly6G+
neutrophils were FACS sorted from the spinal cord, brainstem, and
bone marrow of WT mice at the onset of cEAE, and IFNγRKO mice at
the onset of aEAE. Bone marrow cells from naïve mice were used as
controls. CXCR2 mRNA levels were quantified by qPCR and normalized
to GAPDH (n = 10 WT mice and 15 IFNγRKO mice with EAE, pooled
from two experiments; n = 4 WT naive mice and 5 IFNγRKO naïve
mice). c IFNγR-sufficient and IFNγRKO neutrophils (defined as
CD45+CD11b+Ly6G+) were FACS sorted from the bone marrow, spinal
cord, and brainstem of mixed bone marrow chimeric mice at the
onset of EAE. CXCR2 transcript levels were normalized to GAPDH
(n = 13 mice from two experiments)
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observation was corroborated by qPCR, which revealed
an upregulation of CXCL1 transcripts in choroid plexus
epithelial cells isolated from mice with either cEAE or
aEAE (Fig. 5b and data not shown). We also detected
CXCL1 in astrocytes in the spinal cords of WT hosts
with cEAE (Fig. 5a). We did not detect CXCL1 in infil-
trating inflammatory cells, irrespective of CNS compart-
ment or host genotype. These results corroborate
published data that demonstrates CXCL1 upregulation
in the choroid plexus of C57BL/6 mice with EAE in-
duced by active immunization [16].
Discussion
Based on the results of this study, we propose the follow-
ing hypothetical model by which an IFNγ/CXCL2 axis
regulates the regional localization of inflammatory infil-
trates during EAE. CXCL1 is released by choroid plexus
epithelium in the early stages of both cEAE and aEAE,
and promotes neutrophil migration into the fourth ven-
tricle and meningeal space. In IFNγRKO hosts, the neu-
trophils are then stimulated to migrate deeper into the
brainstem parenchyma by a CXCL2 concentration gradi-
ent, initially generated by activated microglia, and subse-
quently amplified by neutrophils and monocytes as they
accumulate in the brainstem white matter.
Astrocyte-derived CXCL1 might also contribute to the
early infiltration of the brainstem parenchyma by neutro-
phils. CXCL2 production by CNS myeloid cells escalates
during the progression of aEAE, driven by an autocrine
and/or paracrine positive feedback loop (as suggested by
the data in Fig. 4). Conversely, in WT hosts, CXCR2 and
CXCL2 expression in CNS myeloid cell populations is
suppressed by IFNγ that is released by reactivated
myelin-reactive T cells. Consequently, neutrophils do not
penetrate deep into the brainstem white matter. The in-
hibition of CXCR2 and CXCL2 expression by
CNS-infiltrating neutrophils in response to IFNγ signaling
appears to be a cell- and microenvironment-specific
phenomenon, since IFNγ has been reported to actually
promote CXCR2 and CXCL2 production by
non-hematopoietic cells in non-CNS tissues [23–25].
Reminiscent of the results of the current study, infiltrating
neutrophils were recently found to be the major source of
CXCL2 in a mouse model of immune complex-mediated
cutaneous inflammation (ICMCI) [26]. Expression of
CXCL2 by immune complex-activated neutrophils
amplified their recruitment to the skin in an auto-
crine/paracrine manner. The ICMCI model also re-
sembles our Th1-mediated EAE model in that tissue
resident cells were the major source of CXCL1. In
both animal models, differences in the cellular source
and spatial distribution of CXCL1 and CXCL2 trans-
late into distinct roles of those chemokines in the
pathogenic process.
A
B
C
Fig. 4 IFNγ suppresses CXCL2 expression in neutrophils and monocytes
stimulated with CXCR2 or TLR ligands, respectively. a, b Bone marrow
neutrophils were cultured in media alone, or with recombinant CXCL2,
CXCL2 plus IL-1β, CXCL1, or G-CSF, in the presence or absence of IFNγ.
RNA was extracted 1 h later to measure CXCL2 transcript levels via
qPCR. Fold induction of CXCL2 in the stimulated neutrophils over
unstimulated controls was calculated as 2−ΔΔCt, using GAPDH as an
internal control for normalization. Each symbol represents a neutrophil
culture derived from an individual mouse. (a n= 8 mice, with data
pooled from three experiments. b Representative of two experiments
with n= 3 mice each). c Bone marrow monocytes were stimulated with
LPS in the presence or absence of IFNγ for 4 h. Intracellular CXCL2
protein expression was assessed by flow cytometry (Representative of
three experiments with n= 3 mice each)
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Although the model of Th1-mediated aEAE described
here is IL-17 independent, that is not the case for an alter-
native aEAE model induced in C3Heb/Fej mice by the
adoptive transfer of IL-23 polarized, MOG97–114-reactive
CD4+ Th17 cells [13, 19]. The latter model of aEAE, like
ours, is neutrophil dependent and associated with CXCL2
induction in the brain [19]. Astrocytes isolated from the
brain and spinal cord of C3Heb/Fej mice at peak aEAE ex-
press higher levels of CXCL2 mRNA than endothelial cells,
microglia, or CNS-infiltrating myeloid cells [19]. In con-
trast, infiltrating myeloid cells and microglia are a major
source of CXCL2 in the brainstem of C57BL/6 IFNγRKO
recipients following the transfer of encephalitogenic Th1
cells (Figs. 1 and 2). CXCL2 itself, in combination with
IL-1β, is a likely candidate for the inducer CXCL2 in our
model (Fig. 4). We did not detect CXCL2 in GFAP+ astro-
cytes in brainstem sections of symptomatic C57BL/6
IFNγRKO hosts. However, GFAP staining was relatively
sparse in our brainstem sections. In addition, astrocytes
were rare among the CD45− cells that we isolated from
brainstem preparations for flow cytometric analysis (data
not shown). Therefore, we cannot rule out the possibility
that, in our aEAE model, astrocytes and/or other
non-hematopoeitic CNS resident cells contribute to brain-
stem CXCL2 expression in conjunction with myeloid cells.
The contention that IFNγ suppresses aEAE via effects on
multiple cellular targets in parallel is supported by the in-
creased susceptibility of both IFNγRKO ➔WT and
WT➔IFNγRKO bone marrow chimeric mice to aEAE [15].
The intracellular pathways that regulate neutrophil
CXCL2 expression during aEAE remain to be elucidated.
The fact that IFNγ inhibits CXCL2-induced, but not
G-CSF-induced, upregulation of CXCL2 in cultured neu-
trophils (Fig. 4) suggests the co-existence of multiple, par-
allel pathways. LysM-Cre:SOCS3fl/fl conditional knockout
mice develop an atypical form of EAE that is ameliorated
by neutrophil depletion or CXCR2 blockade [27]. Neutro-
phils from LysM-Cre:SOCS3fl/fl mice exhibit enhanced
and prolonged activation of STAT3 in response to stimuli
such as G-CSF. We are currently investigating the role of
a SOCS3/STAT3 immunoregulatory circuit in our model.
Conclusions
The current study adds to a growing body of literature
demonstrating diversity in the dysregulated immune
pathways that drive, and modulate, CNS autoimmune
disease. Clinical variants of human autoimmune demye-
linating disease display different patterns of lesion distri-
bution. For example, the spinal cord is disproportionately
targeted in an opticospinal form of MS that is prevalent in
A B
Fig. 5 CXCL1 is expressed by CNS resident cells during EAE. a CXCL1 (red) was detected in the choroid plexus epithelium in brainstem sections
of IFNγRKO mice at the onset of aEAE (clinical score 1), and in astrocytes in spinal cord sections of WT mice at the onset of cEAE (clinical score 2),
via immunofluorescent histology. Sections were co-stained with antibodies specific for CD45 (green) and GFAP (white), and counterstained with
DAPI (blue). b Choroid plexus samples were obtained at the onset of cEAE or aEAE, or from naïve IFNγRKO mice. CXCL1 transcript was quantified
by qPCR and normalized to GAPDH (n = 4–6/group from two experiments)
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Asia [28, 29]. In contrast, lesion burden is skewed towards
the cerebrum in most individuals in the Western
hemisphere with relapsing-remitting MS [30]. Differences
in underlying immunopathological mechanisms and lesion
distribution between MS patients could correlate with dif-
ferences in environmental triggers, and ultimately translate
into differences in therapeutic responsiveness to individual
disease-modifying drugs [31–33]. Collectively, the current
study, together with previously published studies in aEAE
and cEAE, suggests that actionable therapeutic targets
may differ among MS patients with distinct types of im-
mune dysregulation and clinical phenotypes. Conversely,
in some cases the role of a particular mediator and/or
leukocyte might be universal across individuals within the
same clinical subset (as with the regulatory role of IFNγ in
brainstem inflammation). These observations illustrate the
complexity of the relationship between immunopathologi-
cal pathways and their clinical manifestations. They
underscore the importance of discovering biomarkers that
correlate with underlying immune mechanisms, in
addition to clinical phenomenology, to help guide the
management of inflammatory demyelinating disease in a
customized manner.
Additional files
Additional file 1: Figure S1. The numbers of CNS-infiltrating myeloid
cells are comparable at the onset of cEAE and aEAE. Spinal cords (left
panels) and brainstems (right panels) were harvested at the onset of cEAE in
WT adoptive transfer recipients (blue) or at the onset of aEAE in IFNγRKO
adoptive transfer recipients (red). Inflammatory cells were isolated and
analyzed by flow cytometry. The numbers of CD45hiCD11b+Ly6G−
monocytes/macrophages (upper panels) and CD45hiCD11b+Ly6G+
neutrophils (lower panels) were counted per specimen. Each symbol reflects
the results obtained from an individual mouse. (PDF 694 kb)
Additional file 2: Figure S2. Neutrophils only infiltrate the brainstem
white matter parenchyma during aEAE. Immunofluorescent histology was
performed on brainstem sections obtained at the onset of cEAE (left
panels) or aEAE (right panels) to detect cells expressing CD3ε (green),
Ly6G (red), and DAPI (blue). (PNG 1607 kb)
Additional file 3: Figure S3. Expression of CXCR2 is not altered
produced by CD45+ cells in the brainstem infiltrates during aEAE. Images
of the brainstem section, shown in Fig. 2b, using individual fluorescent
channels. (PDF 3879 kb)
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